References
- NakamuraKWatanabeNOhkawaHEffects on caregiver burden of a donepezil hydrochloride dosage increase to 10 mg/day in patients with Alzheimer’s diseasePatient Prefer Adherence20141581223122825258516
- López-PousaSArranzFJCharacteristics of patients with Alzheimer’s disease who switch to rivastigmine transdermal patches in routine clinical practicePatient Prefer Adherence20137475423341737
- RentzDMLocascioJJBeckerJACognition, reserve, and amyloid deposition in normal agingAnn Neurol201067335336420373347
- ZhangXLiLZhangXPrenatal hypoxia may aggravate the cognitive impairment and Alzheimer’s disease neuropathology in APPSwe/PS1A246E transgenic miceNeurobiol Aging201334366367822795785
- AbdullahLParisDLuisCThe influence of diagnosis, intra- and inter-person variability on serum and plasma Abeta levelsNeurosci Lett20074282–3535817964720
- FrankfortSVTulnerLRvan CampenJPVerbeekMMJansenRWBeijnenJHAmyloid beta protein and tau in cerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literatureCurr Clin Pharmacol20083212313118700307
- Graff-RadfordNRCrookJELucasJAssociation of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer diseaseArch Neurol200764335436217353377
- MayeuxRHonigLSTangMXPlasma A[beta]40 and A[beta]42 and Alzheimer’s disease: relation to age, mortality, and riskNeurology20036191185119014610118
- van OijenMHofmanASoaresHDKoudstaalPJBretelerMMPlasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort studyLancet Neurol20065865566016857570
- GabelleARichardFGutierrezLAPlasma amyloid-β levels and prognosis in incident dementia cases of the 3-City StudyJ Alzheimers Dis201233238139122976074
- AbdullahLLuisCParisDHigh serum Abeta and vascular risk factors in first-degree relatives of Alzheimer’s disease patientsMol Med2009153–49510019081767
- IharaMKalariaRNUnderstanding and preventing the development of post-stroke dementiaExpert Rev Neurother20141491067107725105544
- DreganAWolfeCDGullifordMCDoes the influence of stroke on dementia vary by different levels of prestroke cognitive functioning?: a cohort studyStroke201344123445345124135927
- Al-QazzazNoor KamalAliSawal HamidAhmadSiti AnomCognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessmentNeuropsychiatr Dis Treat2014101677169125228808
- ZhangFengjinJiangLinlanNeuroinflammation in Alzheimer’s diseaseNeuropsychiatr Dis Treat20151124325625673992
- LeeJisunGiordanoSamanthaZhangJianhuaAutophagy, mitochondria and oxidative stress: cross-talk and redox signalingBiochem J201244152354022187934
- TescoGKohYHKangELDepletion of GGA3 stabilizes BACE and enhances beta-secretase activityNeuron200754572173717553422
- MäkinenSvan GroenTClarkeJCoaccumulation of calcium and beta-amyloid in the thalamus after transient middle cerebral artery occlusion in ratsJ Cereb Blood Flow Metab200828226326817653130
- KurapatiKRSamikkannuTAtluriVSKaftanovskayaEYndartANairMPβ-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide APLoS One2014911e11281825415340
- KurapatiKRAtluriVSSamikkannuTNairMPAshwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND)PLoS One2013810e7762424147038
- BlaskoIJellingerKKemmlerGConversion from cognitive health to mild cognitive impairment and Alzheimer’s disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteineNeurobiol Aging200829111117055615